A 22-year-old man with sickle cell disease (HbSS) is hospitalized for a vaso-occlusive crisis involving his lower back and legs. On his second hospital day, he develops a new cough, pleuritic chest pain, and a fever of 38.5°C (101.3°F). Physical examination reveals increased work of breathing and crackles at the left lung base. His oxygen saturation has decreased from 98% to 91% on room air. A chest radiograph demonstrates a new pulmonary infiltrate in the left lower lobe. Laboratory studies show a hemoglobin of 7.2 g/dL (baseline 8.1 g/dL).
Which of the following is the most appropriate next step in the management of this patient?
The correct answer is:
B) Ceftriaxone, azithromycin, and emergent exchange transfusion
This patient meets the diagnostic criteria for acute chest syndrome (ACS), a life-threatening complication of sickle cell disease. ACS is defined by a new pulmonary infiltrate on chest X-ray combined with at least one of the following: fever, cough, chest pain, tachypnea, or hypoxia. The pathophysiology is a vicious cycle of alveolar hypoxia, sickling in the pulmonary vasculature, and subsequent inflammation, often triggered by fat embolism, pulmonary infarction, or infection.
Management must be aggressive and includes:
Antibiotics to cover typical (e.g., S. pneumoniae) and atypical (e.g., Mycoplasma, Chlamydia) pathogens.
Supplemental oxygen to maintain saturation >92%.
Transfusion therapy: Simple transfusion is used for mild cases, but exchange transfusion is indicated for severe disease, respiratory distress, or rapidly progressive infiltrates to reduce the HbS percentage to <30%.
Answer choice A: Administration of intravenous corticosteroids, is incorrect. While steroids may reduce the duration of the hospital stay, they are generally avoided in patients with sickle cell disease because they are associated with a high rate of rebound vaso-occlusive crisis and readmission.
Answer choice C: Discharge with oral amoxicillin-clavulanate, is incorrect. ACS is a medical emergency with high mortality. Management requires inpatient stabilization, intensive monitoring, and parenteral therapy.
Answer choice D: Immediate anticoagulation with heparin, is incorrect. While pulmonary embolism can mimic ACS, the primary issue is vaso-occlusion due to sickled cells and inflammation, not a traditional thrombus. Anticoagulation is not a standard treatment for ACS unless a pulmonary embolism is definitively proven.
Answer choice E: Intravenous fluid bolus of 2 liters of normal saline, is incorrect. Aggressive fluid resuscitation is dangerous in ACS. These patients are at high risk for pulmonary edema and volume overload, which can worsen respiratory failure. Hydration should be cautious and typically kept at no more than maintenance levels.
Key Learning Point
Acute chest syndrome is the leading cause of death in adults with sickle cell disease. It is diagnosed by a new pulmonary infiltrate plus clinical symptoms, including fever, hypoxia, or chest pain. Treatment involves broad-spectrum antibiotics including a macrolide, pain control, incentive spirometry, and transfusion therapy (simple or exchange) to improve oxygen delivery and reduce the concentration of HbS.
